NCT06147388View on ClinicalTrials.gov

Regression of Cervical Precancerous Lesions and Associated Risk Factors

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2027

Conditions

Cervix Uteri SILHPVCIN2CIN3

Interventions

DIAGNOSTIC_TEST

Colposcopy

No surgery, observation

Trial Locations (1)

12800

RECRUITING

General University Hospital, Prague

All Listed Sponsors

lead

General University Hospital, Prague

OTHER